Scientific American reported in 2018 that young blood transfusion was being offered as a paid "trial",[2] which, like Ambrosia's trial,[2][18] had no distinct control group from the treatment; it also charged participants $285,000 per person.[2] Dipnarine Maharaj, a Florida physician running the trial, has previously offered both traditional and nontraditional anti-aging treatments such as stem cell banking.[2] He also has ties to the Hippocrates Health Institute, an organization promoting unproven alternative medicine.[19] This trial was promoted by Bill Faloon,[2] who founded the Life Extension Foundation,[20] which was raided by the FDA In 1987 for illegally importing medicine, though the case was dropped in 1996.[21]
45
Responses